Results 191 to 200 of about 247,999 (295)

Anxiofit‐1 and reduction of subthreshold and mild anxiety: Evaluation of a health claim pursuant to article 14 of regulation (EC) No 1924/2006

EFSA Journal, Volume 24, Issue 3, March 2026.
Abstract Following an application from Anxiofit Ltd. pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Hungary, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked for an opinion on the scientific substantiation of a health claim related to Anxiofit‐1 and reduction of subthreshold and mild ...
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Torsten Bohn, Montaña Cámara, Jacqueline Castenmiller, Stefaan de Henauw, Karen‐Ildico Hirsch‐Ernst, Angeles Jos, Alexandre Maciuk, Inge Mangelsdorf, Breige McNulty, Androniki Naska, Kristina Pentieva, Frank Thies, Ines Drenjančević, Ionut Craciun, Alfonso Siani   +17 more
wiley   +1 more source

Exploring cannabinoid modulation on autophagy mechanisms in Alzheimer's disease: a review. [PDF]

Front Pharmacol
Ntsapi C, Weyers M, Chinheya R, Jim T, Matsabisa M.   +4 more
europepmc   +1 more source

GABAergic mechanisms of excitation and hypersynchrony in adult rat hippocampus [PDF]

, 2003
Uusisaari, Marylka
core  

Cannabinoid Receptor 1 Positive Allosteric Modulators for Posttraumatic Stress Disorder [PDF]

Neuropsychopharmacology, 2017
Anantha, Shekhar, Ganesh A, Thakur
openaire   +2 more sources

Unraveling Endocannabinoid Signaling Pathways in Cisplatin‐Induced Ototoxicity

The FASEB Journal, Volume 40, Issue 4, 28 February 2026.
We performed a comprehensive molecular profiling of the endocannabinoid (eCB) system (ECS) in an auditory Hair cell (HC)‐like cell line (1). Afterwards, we developed suitable in vitro and in vivo models of cisplatin‐induced ototoxicity where we identified distinct components of the ECS (CB2R, DAGLβ and ABHD6) as molecular targets of the drug (2 ...
Sakthimala Palaniappan, Annamaria Tisi, Camilla Di Meo, Cristina Urbano, Georgina E. Fenton, Francesco Della Valle, Federico Fanti, Dario Compagnone, Marc Nazarè, Huib Versnel, Andrea Aramini, Marcello Allegretti, Mauro Maccarrone   +12 more
wiley   +1 more source

Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release.

Neuron, 2016
Daniel J Foster, Jermaine M. Wilson, Daniel H. Remke, M. Mahmood, M. J. Uddin, J. Wess, Sachin Patel, L. Marnett, C. Niswender, Carrie K Jones, Zixiu Xiang, C. Lindsley, J. M. Rook, P. Conn   +13 more
semanticscholar   +1 more source

Neuroprotective Role of Cannabinoid CB₁ and GPR55 Receptors in a Cell Model of Multiple Sclerosis. [PDF]

Mol Neurobiol
Martínez-Pinilla E, Calatayud-Morán JM, Menéndez-Pérez C, Villar-Conde S, Rivas-Santisteban R, Peláez R, Navarro A, Franco R.   +7 more
europepmc   +1 more source

Blockade of cannabinoid 1 receptor improves GLP-1R mediated insulin secretion in mice.

Molecular and Cellular Endocrinology, 2016
I. González-Mariscal, S. Krzysik-Walker, Wook Kim, Michael Rouse, J. Egan   +4 more
semanticscholar   +1 more source

The Endocannabinoid System in Human Disease: Molecular Signaling, Receptor Pharmacology, and Therapeutic Innovation. [PDF]

Int J Mol Sci
Șerban M, Toader C, Covache-Busuioc RA.
europepmc   +1 more source

Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation.

Molecular Endocrinology, 2015
R. P. Picone, D. Kendall
semanticscholar   +1 more source